Nuvilex - NVLX

Nuvilex (NVLX)
Coverage: March 1, 2013 - March 1, 2014
Featured: March 1, 2013

Latest Newsletter Editions

Fri, Oct 17, 2014 @ 07:10 am
Hedge Fund Managers- Drowning At Their High Water Marks It seems like we might have had the capitulation sell off this week, with...
Mon, Jul 21, 2014 @ 06:07 am
Nuvilex (NVLX): Shutting Them Up It's been the only thing worth covering in July-It's been radio silence from Staffing 360 (STAF...
Sun, Jul 13, 2014 @ 08:07 am
Nuvilex (NVXL): A Tradeable Bottom? Well, it's July and we're in the middle of the summer doldrums. Microcap stocks are exceptionally...
Fri, May 30, 2014 @ 09:05 am
Nuvilex (NVLX): Don't Be Fooled By Quiet Trading It's been a rather quiet week on the trading front for Nuvilex (NVLX), but it's anything but quiet on the corporate front. It's...
Thu, May 1, 2014 @ 09:05 am
Nuvilex (NVLX): Proving My Theory Today The last edition I published on Nuvilex (NVLX) back on April 19th suggested we had finally...

Click Here For More Newsletters on NVLX


Latest Blog Entries


Quote Data

Last Trade: N/A Bid: 0.0000
Last Size: 0 Ask: 0.0000
Trade Time: N/A Bid x Ask Size: N/A
Change: +0.0000 (+0.00%) Day's Range: 0.00 - 0.00
Prev Close: 0.0000 52wk Range: 0.00 - 0.00
Open: 0.0000 P/E (ttm): N/A
Volume: 0 EPS (ttm): -0.03
spacer [Chart]

Business Summary



MarketBtye LLC was formerly paid a fee of $10,000 and 1 million newly issued restricted shares of Nuvilex by the company for six months of coverage. The 6 months has expired. On November 1, 2013, MarketByte LLC entered into a consulting agreement with Nuvilex to cover the company for an additional 6 months and received 300,00 newly issued restricted shares. MarketByte LLC currently holds no shares of Nuvilex, and has received $83,155.83 in proceed from sales of NVLX in 2014. At present, MarketByte LLC has no contractual obligation to provide coverage of Nuvilex. Therefore, there are no conflicts of interest.

Recent News Headlines

15 Marijuana Stocks To Watch In 2015
Tue, 06 Jan 2015 16:45:54 GMT
NUVILEX, INC. Financials
Sat, 20 Dec 2014 18:04:13 GMT
Breakthrough Diabetes Research to Be Commercialized by US-Based Nuvilex, Inc.
Mon, 03 Nov 2014 15:49:42 GMT
[Marketwired] - Australian research that has produced a line of insulin producing cells that could eliminate the need for injections for Type 1 diabetics will be commercialized by US company Nuvilex, Inc. and its subsidiaries ...
Nuvilex, Inc. Engaged in "Cutting Edge" Cannabis Preclinical Studies Using Model Compounds With Cell-in-a-Box
Wed, 29 Oct 2014 12:45:00 GMT
[Marketwired] - Nuvilex, Inc. isn't letting the upcoming mid-term elections or the views in Washington, D.C., on medical marijuana slow down its research. The company is currently engaged in preclinical studies at the ...
Nuvilex, Inc. Moves Closer to "Bio-Artificial Pancreas" Diabetes Treatment With License for Insulin-Producing Cells
Tue, 21 Oct 2014 13:00:00 GMT
[Marketwired] - Nuvilex, Inc. has carefully mapped out its plan to develop a diabetes treatment using the Cell-in-a-Box® platform technology. It started in November 2013 when the company acquired the exclusive worldwide ...
Nuvilex's Cancer Treatment Obtaining FDA Orphan Drug Status Would Make Company Attractive Big Pharma Target
Tue, 14 Oct 2014 13:00:00 GMT
[Marketwired] - Nuvilex, Inc. has officially introduced its advanced pancreatic cancer treatment to the U.S. Food and Drug Administration in an application asking the agency to grant orphan drug status to its Cell-in-a-Box®/ifosfamide......